Results from one non-randomized study suggest that the odds of remission, recovery or adequate quality of life with both amisulpride and clozapine were not statistically different from olanzapine. When just those patients in the study who remained on the same treatment for 36 months were considered, the odds of remission with amisulpride and clozapine was lower than olanzapine.